CXI Healthcare Technology Group Limited

KOSDAQ:A900120 Lagerbericht

Marktkapitalisierung: ₩23.1b

CXI Healthcare Technology Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 4/6

CXI Healthcare Technology Group has been growing earnings at an average annual rate of 70.7%, while the Personal Products industry saw earnings growing at 9.9% annually. Revenues have been declining at an average rate of 7% per year. CXI Healthcare Technology Group's return on equity is 6.1%, and it has net margins of 42.3%.

Wichtige Informationen

70.7%

Wachstumsrate der Gewinne

69.3%

EPS-Wachstumsrate

Personal Products Wachstum der Industrie3.8%
Wachstumsrate der Einnahmen-7.0%
Eigenkapitalrendite6.1%
Netto-Marge42.3%
Letzte Ertragsaktualisierung30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Insufficient Growth At CXI Healthcare Technology Group Limited (KOSDAQ:900120) Hampers Share Price

Sep 30
Insufficient Growth At CXI Healthcare Technology Group Limited (KOSDAQ:900120) Hampers Share Price

CXI Healthcare Technology Group (KOSDAQ:900120) Is Experiencing Growth In Returns On Capital

Aug 05
CXI Healthcare Technology Group (KOSDAQ:900120) Is Experiencing Growth In Returns On Capital

Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S

May 30
Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S

How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?

Aufschlüsselung der Einnahmen und Ausgaben

Wie CXI Healthcare Technology Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

KOSDAQ:A900120 Einnahmen, Ausgaben und Erträge (KRW Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 2469,42029,3495,6004,939
31 Mar 2467,19421,0133,4015,231
31 Dec 2368,67317,4464,3055,611
30 Sep 2369,71512,1176,9717,873
30 Jun 2371,6177,52810,4429,750
31 Mar 2379,0651,29413,35212,812
31 Dec 2287,7183,19813,29413,550
30 Sep 2298,0529,53212,3279,969
30 Jun 22101,3765,98112,4379,317
31 Mar 22103,3126,18213,5865,963
31 Dec 21105,3544,30214,5543,998
30 Sep 21108,2842,76215,3905,424
30 Jun 21104,5935,09812,8463,818
31 Mar 2181,035-55,82317,7996,389
31 Dec 2064,812-70,20123,3889,016
30 Sep 2063,264-83,14230,2099,995
30 Jun 2063,406-98,43739,21110,858
31 Mar 2082,358-61,94544,7409,371
31 Dec 19106,374-64,55950,1908,496
30 Sep 19117,046-67,21652,4729,575
30 Jun 19129,309-70,62154,78111,801
31 Mar 19147,921-64,97755,23913,323
31 Dec 18149,568-66,30857,16913,316
30 Sep 18148,347-72,57860,73313,198
30 Jun 18145,264-73,93362,47312,874
31 Mar 18120,456-70,97758,42411,190
31 Dec 17120,228-49,88451,3659,909
30 Sep 17125,336-24,44546,2297,972
30 Jun 17146,31978641,9666,210
31 Mar 17190,10918,96447,1086,736
31 Dec 16228,96929,94554,0397,269
30 Sep 16269,18542,62457,9437,848
30 Jun 16297,60052,39662,2558,734
31 Mar 16311,16460,93161,3078,804
31 Dec 15318,26266,82358,6319,212
30 Sep 15321,33071,47358,0689,382
30 Jun 15317,89573,45255,4609,495
31 Mar 15312,41269,30956,6529,843
31 Dec 14303,79468,53052,5739,487
30 Sep 14291,66465,40149,5549,258
30 Jun 14286,37663,60448,5598,595
31 Mar 14285,46966,36545,2297,919
31 Dec 13279,35262,67245,6907,818

Qualität der Erträge: A900120 has a large one-off gain of ₩10.3B impacting its last 12 months of financial results to 30th June, 2024.

Wachsende Gewinnspanne: A900120's current net profit margins (42.3%) are higher than last year (10.5%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: A900120 has become profitable over the past 5 years, growing earnings by 70.7% per year.

Beschleunigtes Wachstum: A900120's earnings growth over the past year (289.9%) exceeds its 5-year average (70.7% per year).

Erträge im Vergleich zur Industrie: A900120 earnings growth over the past year (289.9%) exceeded the Personal Products industry 30.2%.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: A900120's Return on Equity (6.1%) is considered low.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren